1 paper and 0 clinical trials exploring ayahuasca as a treatment for implementation & service delivery.
Ayahuasca is a botanical decoction combining DMT with MAO-inhibiting harmala alkaloids, producing intense psychedelic effects lasting 3-6 hours. Clinical trials show rapid, large antidepressant effects from a single dose, with a favourable safety profile in controlled settings.
Full Ayahuasca profileThis report explores the implementation and service delivery of psychedelic therapies, focusing on compounds such as psilocybin, MDMA, and LSD in various therapeutic contexts. Recent legislative efforts and clinical trials indicate a growing acknowledgement of the therapeutic potential of psychedelics, particularly in addressing mental health conditions and substance use disorders.
Full Implementation & Service Delivery profileNo clinical trials have been tagged with both Ayahuasca and Implementation & Service Delivery yet.
Trials are continuously being added as new studies are registered.